The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Nefopam Hydrochloride 30 mg Film-coated Tablets

Brown & Burk IR LimitedPA23148/007/001

Main Information

Trade NameNefopam Hydrochloride 30 mg Film-coated Tablets
Dosage FormFilm-coated tablet
Licence HolderBrown & Burk IR Limited
Licence NumberPA23148/007/001

Group Information

ATC CodeN02BG Other analgesics and antipyretics
N02BG06 nefopam


License statusAuthorised
Licence Issued13/04/2018
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back